1)Laxminarayan R, Duse A, Wattal C, et al:Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13:1057-1098,2013
2)厚生労働省:薬剤耐性(AMR)対策アクションプラン2016-2020(http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000120769.pdf)
3)栁原克紀:IDSA/SHEAガイドラインからAntimicrobial stewardshipを読み解く.薬事 56:685-89,2014
4)Dellit TH, Owens RC, McGowan JE Jr, et al:Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159-177,2007
5)Barlam TF, Cosgrove SE, Abbo LM, et al:Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62:e51-e77,2016
6)前田真之:昭和大学病院AST 感染制御専門薬剤師としての視点.薬事 56:709-713,2014
7)Maeda M, Takuma T, Seki H, et al:Effect of interventions by an antimicrobial stewardship team on clinical course and economic outcome in patients with bloodstream infection. J Infect Chemother 22:90-95,2016
8)US GRADE Network:Approach and implications to rating the quality of evidence and strength of recommendations using the GRADE methodology, 2015(http://www.gradeworkinggroup.org/)
9)Coulter S, Merollini K, Roberts JA, et al:The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review. Int J Antimicrob Agents 46:140-149,2015
10)Brink AJ, Messina AP, Feldman C, et al:Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis 16:1017-1025,2016
11)Johannsson B, Beekmann SE, Srinivasan A, et al:Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 32:367-374,2011
12)Gross R, Morgan AS, Kinky DE, et al:Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 33:289-295,2001